Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

October 3, 2020

Study Completion Date

October 23, 2020

Conditions
Pancreas CancerPancreas DiseasePancreas AdenocarcinomaPancreas; FistulaSurgerySurgery--ComplicationsSurgery Site Fistula
Interventions
DEVICE

Hemopatch

Application of hemopatch to the divided end of the pancreas during surgery.

Trial Locations (7)

Unknown

Hamilton Health Sciences, Hamilton

Sunnybrook Health Sciences Centre, Toronto

K7L 2V7

Kingston General Hospital, Kingston

N6A 5W9

London Health Sciences Centre, London

K1H 8L6

The Ottawa Hospital, Ottawa

M5G2N2

University Health Network, Toronto

S7N 0W8

Royal University Hospital, Saskatoon

Sponsors
All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

collaborator

Hamilton Health Sciences Corporation

OTHER

collaborator

The Ottawa Hospital

OTHER

collaborator

Kingston Health Sciences Centre

OTHER

collaborator

Royal University Hospital Foundation

OTHER

collaborator

London Health Sciences Centre

OTHER

collaborator

University Health Network, Toronto

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER

NCT03410914 - Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy | Biotech Hunter | Biotech Hunter